Literature DB >> 3461456

Extrachromosomal sequences of hepatitis B virus DNA in peripheral blood mononuclear cells of acquired immune deficiency syndrome patients.

C A Noonan, B Yoffe, P W Mansell, J L Melnick, F B Hollinger.   

Abstract

The primary etiologic agent of the acquired immune deficiency syndrome (AIDS) is a human T-lymphotropic retrovirus (the AIDS virus). However, the pathogenesis of this virus suggests that other cofactors may contribute to the development of clinically overt disease. The hepatitis B virus (HBV) has been implicated as a potential cofactor because HBV and AIDS virus infections frequently coexist, striking similarities exist in their epidemiologic patterns, and recent data indicate that HBV is lymphotropic. To establish the prevalence of HBV infections in lymphoid cells from individuals with AIDS-related disorders, sera and peripheral blood mononuclear cells (PBMC) from 16 males with AIDS virus infections were examined for the presence of HBV DNA by DNA X DNA blot hybridization. Fifteen (94%) of these individuals had serologic evidence of a recent or prior HBV infection. HBV DNA was detected in the PBMC of all of these patients, regardless of existing HBV serology. Among the 36 control individuals without AIDS-related symptomatology, PBMC-associated HBV DNA was detected in 8 of 14 carriers of hepatitis B surface antigen (HBsAg) and in 3 of 10 individuals immune to HBV, but it was absent from the PBMC of 12 individuals without HBV infection. In all instances, the HBV DNA was extrachromosomal and existed as replicative intermediates or high molecular weight oligomers of the viral genome. Replicative intermediates and serum-associated HBV DNA were detected in all hepatitis B e antigen-positive carriers, regardless of their clinical status. In contrast, the high molecular weight oligomers of HBV DNA were detected in the PBMC of all of the AIDS virus-infected patients examined, but in only 33% of those in the control group who had evidence of HBV infection. This finding suggests that a unique and complex HBV-host-cell interaction exists in patients infected with the AIDS virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3461456      PMCID: PMC386356          DOI: 10.1073/pnas.83.15.5698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals.

Authors:  J A Levy; J Shimabukuro
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

2.  Hepatitis B virus infection in the acquired immunodeficiency syndrome.

Authors:  V K Rustgi; J H Hoofnagle; J L Gerin; E P Gelmann; C M Reichert; J N Cooper; A M Macher
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

3.  Detection of hepatitis B virus DNA in mononuclear blood cells.

Authors:  P Pontisso; M C Poon; P Tiollais; C Brechot
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

4.  Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen.

Authors:  C Bréchot; F Degos; C Lugassy; V Thiers; S Zafrani; D Franco; H Bismuth; C Trépo; J P Benhamou; J Wands
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

5.  Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.

Authors:  C A Ludlam; J Tucker; C M Steel; R S Tedder; R Cheingsong-Popov; R A Weiss; D B McClelland; I Philp; R J Prescott
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

6.  Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex.

Authors:  F Laure; D Zagury; A G Saimot; R C Gallo; B H Hahn; C Brechot
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

7.  Evidence of extrachromosomal forms of hepatitis B viral DNA in a bone marrow culture obtained from a patient recently infected with hepatitis B virus.

Authors:  E Elfassi; J L Romet-Lemonne; M Essex; M Frances-McLane; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources.

Authors:  S Z Salahuddin; P D Markham; M Popovic; M G Sarngadharan; S Orndorff; A Fladagar; A Patel; J Gold; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Clinical significance of enhanced detection of HBsAg by a monoclonal radioimmunoassay.

Authors:  E Ben-Porath; J Wands; M Gruia; K Isselbacher
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

10.  Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization.

Authors:  H E Blum; A T Haase; J D Harris; D Walker; G N Vyas
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

View more
  17 in total

1.  Reactivation of hepatitis B virus in a previously immune patient with human immunodeficiency virus infection.

Authors:  B Vandercam; C Cornu; J L Gala; A Geubel; M Cahill; M E Lamy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

Review 2.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

3.  Transcriptional trans-activating function of hepatitis B virus.

Authors:  J S Twu; R H Schloemer
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

4.  Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region.

Authors:  P Ostapchuk; G Scheirle; P Hearing
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

Review 5.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

6.  Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

Authors:  M G Brook; J A McDonald; P Karayiannis; L Caruso; G Forster; J R Harris; H C Thomas
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

7.  Detection of HIV genome in HIV antibody negative men.

Authors:  M Pezzella; F Caprilli; N Vonesch; P Cordiali-Fei; G Gentili; E Sturchio; E Mannella
Journal:  Genitourin Med       Date:  1989-10

8.  Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects.

Authors:  M Clementi; A Manzin; P Bagnarelli; S Menzo; P E Varaldo; G Carloni
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X.

Authors:  J S Twu; C A Rosen; W A Haseltine; W S Robinson
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

10.  Detection of hepatitis B virus DNA and determination of surface antigen expression in peripheral blood mononuclear cells from patients with AIDS.

Authors:  C Malavé Lara; M T Gorriño; C Campelo; P Lardelli; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.